Understanding clinical trials in migraine

Journal of Headache and Pain

Volumn 7, Issue 2, 2006, Pages 101-108

  Tfelt Hansen, Peer ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Head to head analyses; Meta analyses; Migraine; Randomized clinical trials

Indexed keywords

ALMOTRIPTAN; ELETRIPTAN; NARATRIPTAN; PLACEBO; RIZATRIPTAN; SUMATRIPTAN; TOPIRAMATE; TRIPTAN DERIVATIVE; ZOLMITRIPTAN;

CLINICAL EFFECTIVENESS; CLINICAL RESEARCH; CLINICAL TRIAL; CONFIDENCE INTERVAL; DRUG EFFICACY; HUMAN; MEDICAL LITERATURE; META ANALYSIS; METHODOLOGY; MIGRAINE; PAIN ASSESSMENT; PRIORITY JOURNAL; PUBLICATION; REVIEW; STANDARDIZATION; SYSTEMATIC REVIEW; TREATMENT OUTCOME; CONTROLLED CLINICAL TRIAL; INFORMATION PROCESSING; RANDOMIZED CONTROLLED TRIAL;

CLINICAL TRIALS; DATA COLLECTION; HUMANS; META-ANALYSIS; MIGRAINE DISORDERS; RANDOMIZED CONTROLLED TRIALS; RESEARCH DESIGN;

EID: 33745998778     PISSN: 11292369     EISSN: 11292377     Source Type: Journal    
DOI: 10.1007/s10194-006-0278-2     Document Type: Review

References (61)

1. Spilker B (1991) Guide to clinical trials. Raven Press, New York
2. Guyatt GH, Sackett DL, Cook DJ (1993) Users' guides to the medical literature. II. How to use an article about therapy or prevention. A. Are the results of the study valid? Evidence-Based Working Group. JAMA 270:2598-2601
3. Sackett DL, Rosenberg WM, Gray JA, Haynes RB, Richardson WS (1996) Evidence based medicine: What it is and it isn't. BMJ 312:71-72
4. Rochon PA, Gurwitz JH, Cheung CM, Hayes JA, Chalmers TC (1994) Evaluating the quality of articles published in journal supplements compared with the quality of those published in the parent journal. JAMA 272:108-113
5. Begg C, Cho M, Eastwood S, Horton R, Moher D, Olkin L, Pitkin R, Rennie D, Schulz KF, Simel D, Stroup DF (1996) Improving the quality of reporting randomized controlled trials. The CONSORT statement. JAMA 276:637-639
6. Dans AL, Dans LF, Guyatt GH, Richardson S (1998) Users' guides to the medical literature: XIV. How to decide on the applicability of clinical trial results to your patient. Evidence-Based Medicine Working Group. JAMA 279:545-549
7. Als-Nielsen B, Chen W, Gluud C, Kjaergård LL (2003) Association of funding and conclusions in randomized drug trials: A reflection of treatment effect or adverse evens? JAMA 290:921-928
8. Chan AW, Hrobjartson A, Haahr MT, Gotzsche PC, Altman DG (2004) Empirical evidence for selective reporting of outcomes in randomized trials: Comparison of protocols and published articles. JAMA 291:2457-2465
9. Dahlöf CGH, Rolan P, Tfelt-Hansen P (2006) Principles of clinical pharmacology, randomized controlled clinical trials and evidence based medicine in headache. In: Olesen J, Goadsby PJ, Ramadan NM, Tfelt-Hansen P, Welch KMA (eds) The headaches, 3rd edn. Lippincott Williams & Wilkins, Philadelphia, pp 55-61
10. Diener H-C, Dowson AJ, Ferrari M, Nappi G, Tfelt-Hansen P, on behalf of the Study Group (1999) Unbalanced randomisation influences placebo response: Scientific versus ethical issues around the use of placebo in migraine trials. Cephalalgia 19:699-700
11. International Headache Society Clinical Trial Subcommittee (2000) Guidelines for controlled trials of drugs in migraine, 2nd edn. Cephalalgia 20:765-786
12. Tfelt-Hansen P, Teall J, Rodriguez F et al and 030 Study Group (1998) Oral rizatriptan versus oral sumatriptan: A direct comparative study in the acute treatment of migraine. Headache 38:748-755
13. Goldstein J, Ryan R, Jiang K et al and the Rizatriptan Protocol 046 Study Group (1998) Crossover comparison of rizatriptan 5 mg and 10 mg versus sumatriptan 25 mg and 50 mg in migraine. Headache 38:737-747
14. Schoenen J, Jacquy M, Lenaerts M (1998) Effectiveness of high-dose riboflavin in migraine prophylaxis: A randomized controlled trial. Neurology 50:466-470
15. Oral Sumatriptan Dose Defining Study Group (1991) Sumatriptan - an oral dose-defining study. Eur Neurol 31:300-305
16. Brandes JL, Saper JR, Diamond M, Couch JR, Lewis DW, Schmitt J, Neto W, Schwabe S, Jacobs D; MIGR-002 Study Group (2004) Topiramate for migraine prevention: A randomized controlled trial. JAMA 291:965-973
17. Silberstein SD, Neto W, Schmitt J, Jacobs D; MIGR-001 Study Group (2004) Topiramate in migraine prevention: Results of a large controlled trial. Arch Neurol 61:490-495
18. Ferrari MD, Roon KI, Lipton RB, Goadsby PJ (2001) Oral triptans (serotonin 5-HT(1B/1D) agonists) in acute migraine: A meta-analysis of 53 trials. Lancet 358:1668-1675
19. Ferrari MD, Goadsby PJ, Roon KI, Lipton RB (2002) Triptans (serotonin, 5-HT1B/1D agonists) in migraine: Detailed results and methods of a meta-analysis of 53 trials. Cephalalgia 22:633-658
20. Saxena PR, Tfelt-Hansen P (2005) Triptans, 5HT1B/1D agonists in the acute treatment of migraine. In: Olesen J, Goadsby PJ, Ramadan NM, Tfelt-Hansen P, Welch KMA (eds) The headaches, 3rd edn. Lippincott, Williams & Wilkins, Philadelphia, pp 469-503
21. Multinational Oral Sumatriptan and Cafergot Comparative Study Group (1991) A randomized, double-blind comparison of sumatriptan in the acute treatment of migraine. Eur Neurol 31:314-322
22. Diener HC, Tfelt-Hansen P, Dahlöf C, Lainez MJA, Sandrini G, Wang S-J, Neto W, Vijapurkar U, Doyle A, Jacobs D (2004) Topiramate in migraine prophylaxis. Results from a placebo-controlled trial with propranolol as an active control. Eur Neurol 251:943-950
23. Geraud G, Olesen J, Pfaffenrath V, Tfelt-Hansen P, Zupping R, Diener H-C, Sweet R, on behalf of the Study Group (2000) Comparison of the efficacy of zolmitriptan and sumatriptan: Issues in migraine trial design. Cephalalgia 20:30-38
24. Göbel H, Winter P, Boswell D, Crisp A, Becker W, Hauge T, Mihout B, Niewold J, Torring J (2000) Comparison of naratriptan and sumatriptan in recurrence-prone migraine patients. Naratriptan International Study Group. Clin Ther 22: 981-989
25. Kolodny A, Polis A, Battisti WP, Johnson-Pratt L, Skobieranda F; Rizatriptan Protocol 052 Study Group (2004) Comparison of rizatriptan 5 mg and 10 mg tablets and sumatriptan 25 mg and 50 mg tablets. Cephalalgia 24:540-546
26. Dowson AJ, Massiou H, Lainez JM, Cabarrocas X (2002) Almotriptan is an effective and well-tolerated treatment for migraine pain: Results of a randomized, double-blind, placebo-controlled clinical trial. Cephalalgia 22:453-461
27. Spierings ELH, Gomez-Mancilla B, Grosz D, Rowland CR, Whaley FS, Jirgens KJ (2001) Oral almotriptan vs oral sumatriptan in the abortive treatment of migraine. A double-blind, randomized, parallel-group, optimum-dose comparison. Arch Neurol 58:944-950
28. Cabarrocas X (2004) Reply to Tfelt-Hansen. Cephalalgia 24:688-689
29. Diener HC, Ryan R, Sun W, Hettiriarachchi J (2004) The 40-mg dose of eletriptan: Comparative efficacy and tolerability versus sumatriptan 100 mg. Eur J Neurol 11:125-134
30. Geraud G, Spierings ELH, Keywood C (2002) Tolerability and safety of frovatriptan with short- and long-term use for treatment of migraine and in comparison with sumatriptan. Headache 42[Suppl 2]:93-99
31. Migraine-Nimodipine European Study Group (MINES) (1989) European multicenter trial of nimodipine in the prophylaxis of common migraine (migraine without aura). Headache 29:633-638
32. Tfelt-Hansen P, Standnes B, Kangasneimi P, Hakkarainen H, Olesen J (1984) Timolol vs propranolol vs placebo in common migraine prophylaxis. A double blind multicenter study. Acta Neurol Scand 69:1-8
33. Mathew NT, Schoenen L, Winner P, Muirhead N, Sikes CR (2003) Comparative efficacy of eletriptan 40 mg versus sumatriptan 100 mg. Headache 43:214-222
34. Tfelt-Hansen P, Rolan P (2006) β-Adrenoceptor blocking drugs in migraine prophylaxis. In: Olesen J, Goadsby PJ, Ramadan NM, Tfelt-Hansen P, Welch KMA (eds) The headaches, 3rd edn. Lippincott, Williams & Wilkins, Philadelphia, York, pp 519-528
35. Pilgrim AJ (1991) Methodology of clinical trials of sumatriptan in migraine and cluster headache. Eur Neurol 31:295-299
36. Tfelt-Hansen P, De Vries P, Saxena PR (2000) Triptans in migraine. A comparative review of pharmacology, pharmacokinetics and efficacy. Drugs 60:1259-1287
37. Massiou H, Tzourio C, el Amrani M, Bousser MG (1997) Verbal scales in the acute treatment of migraine: Semantic categories and clinical relevance. Cephalalgia 17:37-39
38. Subcutaneous Sumatriptan International Study Group (1991) Treatment of migraine attacks with sumatriptan. N Engl J Med 325:316-321
39. Cady RK, Wendt JK, Kirchner JR, Sargent JD, Rothrock JF, Skaggs H (1991) Treatment of acute migraine with subcutaneous sumatriptan. JAMA 265:2831-2835
40. Sumatriptan Auto-Injector Study Group (1991) Self-treatment of acute migraine with subcutaneous sumatriptan using an auto-injector device. Eur Neurol 31:323-331
41. Oral Sumatriptan and Aspirin plus Metoclopramide Comparative Study Group (1992) A study to compare oral sumatriptan with oral aspirin plus oral metoclopramide in the acute treatment of migraine. Eur Neurol 32:177-184
42. Bousser MG, d'Allens H, Richard A, and the Early-Morning Migraine Sumatriptan Study Group (1993) Efficacy of subcutaneous sumatriptan in the acute treatment of early-morning migraine: A placebo-controlled study. J Intern Med 234:211-216
43. Mathew NT, Dexter J, Couch J et al (1992) Dose ranging efficacy and safety of subcutaneous sumatriptan in the acute treatment of migraine. Arch Neurol 49:1271-1276
44. Russel MB, Holm-Thomsen OE, Nielsen MR, Cleal A, Pilgrim AJ, Olesen J (1994) A randomized, double-blind, placebo-controlled crossover study of subcutaneous sumatriptan in general practice. Cephalalgia 14:291-296
45. Jensen K, Tfelt-Hansen P, Hansen EW, Krris EH, Pedersen OS (1995) Introduction of a novel self-injector for sumatriptan. A controlled clinical trial in general practice. Cephalalgia 15:423-429
46. Cutler N, Mushet GR, Davis R, Clements MS, Whitcher L (1995) Oral sumatriptan for the acute treatment of migraine: Evaluation of three dosage strengths. Neurology 45:S5-S9
47. Tfelt-Hansen P, Henry P, Mulder K, Scheldewaert RG, Schoenen J, Chazot G (1995) The effectiveness of combined oral lysine acetylsalicylate and metoclopramide compared with oral sumatriptan for migraine. Lancet 346:923-926
48. Tfelt-Hansen P (2006) A review of evidence-based medicine and meta-analytic reviews in migraine. Cephalalgia (submitted for publication)
49. Aschcroft DM, Millson D (2004) Naratriptan for the treatment of acute migraine: Meta-analysis of randomised controlled trials. Pharmacoepidemiol Drug Saf 13:73-82
50. Gawel MJ, Worthington I, Maggisano A (2001) A systematic review of the use of triptans in acute migraine. Can J Neurol Sci 28:30-41
51. Oldman AD, Smith LA, McQuay HJ, Moore RA (2000) Pharmacological treatments for acute migraine: Quantitative systematic review. Pain 97:247-257
52. Oldman AD, Smith LA, McQuay HJ, Moore RA (2001) Rizatriptan for acute migraine. Cochrane Database Syst Rev (3):CD003221
53. Smith LA, Oldman AD, McQuay HJ, Moore RA (2001) Eletriptan for acute migraine. Cochrane Database Syst Rev (3):CD00324
54. Tfelt-Hansen P (1998) Efficacy and adverse events of subcutaneous, oral and intranasal sumatriptan used for migraine treatment: A systematic review based on number needed to treat. Cephalalgia 18:532-538
55. Linde K, Rossnagel K (2004) Propranolol for migraine prophylaxis. Cochrane Database Syst Rev (2):CD003225
56. Pittler MH, Ernst E (2004) Feverfew for preventing migraine. Cochrane Database Syst Rev (1):CD002286
57. Chronicle E, Mulleners W (2004) Anticonvulsant drugs for migraine prophylaxis. Cochrane Database Syst Rev (3):CD003226
58. McCrory D, Gray RN (2003) Oral sumatriptan for acute migraine. Cochrane Database Syst Rev (3):CD002915
59. Oldman AD, Smith LA, McQuay HJ, Moore RA (2000) Pharmacological treatments for acute migraine: Quantitative systematic review. Pain 97:247-257
60. Headache Classification Committee of the International Headache Society (1988) Classification of headache disorders, cranial neuralgias and facial pain. Cephalalgia 8[Suppl 7]:1-96
61. Tfelt-Hansen P, Schoenen J, Lauret D (1997) Success rates of combined oral lysine acetylsalicylate and metoclopramide, oral sumatriptan, and placebo depend on initial headache severity. A preliminary retrospective analysis. In: Olesen J, Tfelt-Hansen P (eds) 6th International Headache Research Seminar. Headache treatment. Trial methodology and new drugs. Lippincott-Raven, New York, pp 103-106